Novel drug safe, efficacious in patients with HDV-related advanced liver disease
Treatment with REP 2139-Mg (REP), a nucleic acid polymer, demonstrates efficacy and an acceptable safety profile among patients with hepatitis D virus (HDV) and advanced chronic liver disease (CLD), reports a recent study.
Novel drug safe, efficacious in patients with HDV-related advanced liver disease
10 Mar 2026